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Background:Membrane-associated UCH-L1 has been proposed as a target for treating neurodegeneration.
Results: UCH-L1 association with neuronal membranes does not involve farnesylation. C-terminal truncation causes protein
misfolding and neuronal death.
Conclusion: The C terminus of UCH-L1 regulates protein aggregation and stability.
Significance: The CTT4 mutant provides a model for studying neurotoxic UCH-L1 aggregation events.
Ubiquitin C-terminal hydrolase L1 (UCH-L1) is a deubiquiti-
nating enzyme that is highly expressed in neurons. A possible
role for UCH-L1 in neurodegeneration has been highlighted
because of its presence in Lewy bodies associated with Parkin-
son disease and neurofibrillary tangles observed in Alzheimer
disease. UCH-L1 exists in two forms in neurons, a soluble cyto-
plasmic form (UCH-L1C) and a membrane-associated form
(UCH-L1M). Alzheimer brains show reduced levels of soluble
UCH-L1C correlating with the formation of UCH-L1-immuno-
reactive tau tangles, whereas UCH-L1M has been implicated in
-synuclein dysfunction. Given these reports of divergent roles,
we investigated the properties of UCH-L1 membrane associa-
tion. Surprisingly, our results indicate that UCH-L1 does not
partition to the membrane in the cultured cell lines we tested.
Furthermore, in primary cultured neurons, a proportion of
UCH-L1M does partition to the membrane, but, contrary to a
previous report, this does not require farnesylation. Deletion of
the four C-terminal residues caused the loss of protein solubil-
ity, abrogation of substrate binding, increased cell death, and an
abnormal intracellular distribution, consistent with protein
dysfunction and aggregation. These data indicate that UCH-L1
is differently processed in neurons compared with clonal cell
lines and that farnesylation does not account for the membrane
association in neurons.
Ubiquitination is a dynamic, posttranslational modification
that is fundamentally important in controllingmultiple aspects
of neuronal function, including turnover, trafficking, and syn-
aptic plasticity (1, 2). Indeed, dysfunction of ubiquitin metabo-
lism is a hallmark of many neurodegenerative diseases, and
abnormal accumulation of ubiquitinated proteins is associated
with Parkinson disease, Alzheimer disease, and amyotrophic
lateral sclerosis (3, 4).
Ubiquitin C-terminal hydrolase L1 (UCH-L1) is a highly
abundant neuronal deubiquitinase, a cysteine protease that
cleaves small peptide adducts from the C terminus of ubiquitin.
Despite the fact thatUCH-L1 comprises 1–5%of total neuronal
protein (5) and has been shown to play a role in monoubiquitin
homeostasis (6), the wider functional roles of UCH-L1 in vivo
remain to be determined.
UCH-L1 binds ubiquitin with high affinity but possesses
poor hydrolase activity in vitro, especially in comparison with
the more widely expressed UCH-L3, with which it shares 52%
sequence homology (7). Aside from its function as a deubiquiti-
nase, it has been suggested that UCH-L1 can dimerize to act as
an E4 ubiquitin ligase, resulting in accumulation of polyubiq-
uitinated -synuclein (8).
Interestingly, UCH-L1 can partition into both cytosolic
(UCH-L1C) and membrane (UCH-L1M) fractions. In neurons,
it has been estimated that 20–50% is membrane-associated
(9–11), but the mechanisms and consequences of neuronal
membrane association are not understood.
-Synuclein accumulates in the insoluble protein aggregates
characteristic of Parkinson disease and other synucleinopathies
(12). Intriguingly, previous studies have suggested that that
membrane-associated UCH-L1 can stabilize -synuclein levels
(8, 9) and that these effects vary under normal or pathological
conditions (13), raising the possibility thatUCH-L1Mcould be a
target for neurodegenerative drug therapy (9).
One report has suggested that the membrane association of
UCH-L1 is due to farnesylation of an atypical consensus site (9).
Therefore, given the potentially important implications for
progression and treatment of neurodegenerative disease, we
sought to further characterize the membrane-associated form
of UCH-L1.
In this study we did not detect significant levels of mem-
brane-associated UCH-L1 in any of the clonal cell lines we
investigated, suggesting thatmembrane-association ofUCH-L1 is
neuron-specific. Our results also indicate that the membrane
association of UCH-L1 in neurons is not dependent on farne-
sylation or interaction with ubiquitin or species containing
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ubiquitin-like folds because the C220S, C90S, and D30Kmuta-
tions did not reduce the proportion of UCH-L1 in the mem-
brane fraction. Furthermore, deletion of the final four amino
acids of UCH-L1 (CKAA) caused the loss of ubiquitin substrate
binding, increased neuronal death, altered UCH-L1 distribu-
tion within neurons, and removed soluble, cytoplasmic
UCH-L1 with a corresponding increase in Triton X-100-insol-
uble UCH-L1. A proportion of truncated UCH-L1 was still
detected in the membrane fraction, but the levels of soluble
cytosolic UCH-L1 were significantly decreased. Circular dichr-
oism analysis of WT and a C-terminal truncation mutant
(CTT4) revealed that the removal of the last four residues of
UCH-L1 caused a minor disruption to the secondary structure
but dramatically increased aggregation.
These changes are in line with previous reports on the dis-
ruption to the tertiary structure and aggregation of UCH-L1
and are consistent with the distribution and soluble proper-
ties of UCH-L1 in Alzheimer brains (14, 15), suggesting that
this C-terminal truncation may provide a model for studying
neuronal cell death arising from UCH-L1 misfolding and
aggregation.
EXPERIMENTAL PROCEDURES
Cell Culture—Primary hippocampal and cortical neuronal
cultures were prepared from embryonic day 18 rats exactly as
described previously (16). The N2a, HEK293T, and COS7 cell
lines were maintained using standard protocols, and N2a cell
differentiation and neurite outgrowth were induced by serum
starvation for 24 h.
Immunoblotting—All SDS-PAGE andWestern blotting pro-
cedures were carried out according to standard protocols. The
following primary antibodies were used: mouse anti-UCH-L1
(31A3, a gift from Professor Ian Day, University of Bristol, and
Prof. Rod Thompson, 1:10,000), rabbit anti-GluA1 (Millipore,
1:1000), rabbit anti-RhoGDI (Abcam, 1:5000), mouse anti-H-
ras (Santa Cruz Biotechnology, 1:1000), mouse anti-Rac1
(Santa Cruz Biotechnology, 1:1000), rabbit anti-HA (Abcam,
1:5000), goat anti-Lamin B (Santa Cruz Biotechnology, 1:2000),
and rabbit anti-PSD95 (Abcam, 1:1000). All blots were devel-
oped using Li-Cor Odyssey imaging software, except for anti-
Lamin B, which was developed on film using HRP-conjugated
anti-goat (Sigma, 1:10,000). For Li-Cor Odyssey Western blot
imaging, the IRDye secondary antibodies (all fromLi-Cor) used
were 800CW donkey anti-mouse, 800CW donkey anti-rabbit,
680RD donkey anti-mouse, and 680RD donkey anti-rabbit, all
1:10,000. Western blot signal quantification was performed
using Li-Cor Odyssey imaging software.
Subcellular Fractionation of Rat Brain—Fractions were
obtained as described previously (17).
Subcellular Fractionation of Day in Vitro 18 Cultured Corti-
cal Neurons and Cell Lines—Cells were scraped in detergent-
free subcellular fractionation buffer (250 mM sucrose, 20 mM
HEPES (pH 7.4), 10mMKCl, 1.5mMMgCl2, 1mM EDTA, 1mM
DTT, and protease inhibitors (Roche)), lysed by passing the cell
suspension through a 25-gauge needle 12 times using a 1-ml
syringe, and then sonicated briefly three times on low power.
Lysates were centrifuged at 100,000 g in a benchtop ultracen-
trifuge (Beckman) for 1 h at 4 °C. The supernatant was retained
as the cytosolic fraction. The pellet was washed three times in
subcellular fractionation buffer and resuspended in a standard
lysis buffer containing 1% Triton and 0.1% SDS and solubilized
on a rotating wheel at 4 °C for 30 min. The suspension was
centrifuged at 10,000 g in a benchtop centrifuge for 10min at
4 °C. The supernatant was retained as the membrane fraction.
The Triton X-100-insoluble fraction was prepared by resus-
pending the remaining pellet in lysis buffer containing 1% Tri-
ton and 0.1% SDS, rotated at 4 °C for 30 min, passed through a
25-gauge needle 12 times using a 1-ml syringe, and then soni-
cated three times on low power. Protein concentration was
determined using a Bradford assay (Bio-Rad) to determine pro-
tein concentration compared with a set of BSA standards.
Sarkosyl solubility was determined by resuspending the Triton
X-100-insoluble fraction in lysis buffer containing 1% N-lau-
roylsarcosine sodium salt (Sigma), passed through a needle and
sonicated as before, rotated at room temperature for 1 h, and
ultracentrifuged at 100,000 g at 4 °C for 45 min. 20 l of the
supernatant was loaded on the gel as the sarkosyl-soluble frac-
tion. The remaining pellet was resuspended in lysis buffer con-
taining 2% SDS, passed through a needle, resonicated, and then
rotated on awheel at room temperature for a further 30min. 20
l was loaded on the gel as the sarkosyl-insoluble fraction.
Farnesyltransferase Inhibitor Assay—Cultured cortical neu-
rons were treated with DMSO (Sigma) or the farnesyltrans-
ferase inhibitor FTI-276 (Calbiochem) for 48 h prior to under-
going the subcellular fractionation protocol at day in vitro 18 as
described above.
Molecular Biology—The GFP-UCH-L1 human cDNA plas-
midwas a gift fromProf.Mike Clague (University of Liverpool).
His6-TAT-HA-UCH-L1 was a gift from Dr. Ottavio Arancio.
HA-UCH-L1 constructswere generated using standard cloning
procedures and PCR-basedmutagenesis. Sindbis virus express-
ing HA-UCH-L1 constructs were created using the pSinRep5
plasmid and Ambion virus production tools.
UbVME Binding Assay—Cultured cortical neurons were
infected with Sindbis virus-expressing HA-UCH-L1 constructs
for 24 h prior to lysis. N2a cells were transfected with HA-
UCH-L1 constructs at 75% confluency using Lipofectamine
LTXPlus (Invitrogen) for 40 h prior to lysis. 20g of cell lysates
was incubated with 2 M of UbVME2 substrate (Boston
Biochem) for 1 h at 37 °C and then subjected to SDS-PAGE.
Microscopy—For fixed cell confocal imaging, standard 4%
PFA fixation and immunostaining protocols were used on day
in vitro 18 dissociated hippocampal neurons infected with
Sindbis virus expressingHA-UCH-L1 constructs for 24 h.Anti-
UCH-L1 and anti-HA antibodies were used at 1:500. Fluoro-
phore-conjugated secondary antibodies used were goat anti-
mouse-DyLight 488 and goat anti-rabbit DyLight 649 (Jackson
ImmunoResearch Laboratories) and Hoechst nuclear stain
(Thermo Scientific, 1:10,000). Confocal imaging was per-
formed using a 63 oil immersion objective lens (numerical
aperture, 1.4) on a Zeiss LSM 150 META inverted confocal
microscope.Maximum projection confocal z stacks were taken
2 The abbreviations used are: UbVME, ubiquitin vinyl methyl ester; 3CS, three
cysteines; CTT, C-terminal truncation mutant; FTI, farnesyl transferase
inhibitor.
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using 0.4-m steps using a 1024 1024 pixel resolution and a
pinhole 1 airy unit and prepared using ImageJ software
(National Institutes of Health).
Cell Death Assay—lactate dehydrogenase levels in condi-
tioned neuronal culture media were assessed using an in vitro
toxicology assay kit (Sigma). Briefly, day in vitro 18 dissociated
cortical neurons cultured in 3-cm dishes were infected with
Sindbis virus expressing HA-UCH-L1 constructs for 24 h. 100
l of conditioned culturemediumwas taken from each dish. 30
l of medium was transferred to each well of a 96-well plate. A
lactate dehydrogenase assay mixture containing substrate,
cofactor, and dye solutions was prepared according to the
instructions of the manufacturer, and 60 l of the mixture was
added to each well of a 96-well plate. Following 25 min of incu-
bation, the reaction was quenched using 10 l of 1 N HCl, and
the absorbance at 492 nm and at reference 620 nm was mea-
sured using a Tecan program on a plate reader.
Circular Dichroism—Purified TAT-HA-UCH-L1 and TAT-
HA-CTT4 were analyzed by circular dichroism spectroscopy
at a concentration of 5 M in PBS with 1 mM Tris (2-carboxy-
ethyl)phosphine and 0.01% SDS. CD data were collected on a
Jasco J810 spectropolarimeter fittedwith a Peltier temperature-
controlled sample stage. Samples were placed in a 1-mm path
length quartz cuvette (Starna), and the scan rate was 50 nm
min1 with a 1-nm interval, a 1-nm bandwidth, and a 1-s
response time.
RESULTS
UCH-L1 Partitions to the Membrane in Primary Cultured
Cortical Neurons but Not in Clonal Cell Lines—Subcellular
fractionation of adult rat brainwas used to identify the neuronal
compartments that contain UCH-L1. As expected, UCH-L1
was most abundant in the cytosolic fractions, but it was also
detected in several of the membrane-enriched fractions (Fig.
1A). Immunoblotting for the cytosolic marker RhoGDI showed
that the presence of UCH-L1 in these fractions was not due to
cytosolic contamination.
To determine the proportion of membrane to cytosolic
UCH-L1, we next optimized a subcellular fractionation proto-
col for cultured cortical neurons to efficiently separate soluble
cytosolic proteins from transmembrane proteins, whichwe val-
idated by immunoblotting for cytosolic (RhoGDI) and mem-
brane (GluA1) protein markers (Fig. 1B). Importantly, we also
confirmed that this protocol preserves the cytosolic/membrane
ratio of proteins that partition into both compartments by ana-
lyzing Rac1. Rac1 is a partially prenylated protein that is post-
translationally modified by geranylgeranylation (18) leading to
both cytosolic and peripheralmembrane-associated forms (Fig.
1B). UCH-L1 was detected byWestern blot in both the cytoso-
lic and membrane fractions (Fig. 1B) with 30% UCH-L1M
(Fig. 1C), consistent with values reported previously and,
potentially, for a role of farnesylation in regulating membrane
partitioning (9, 11).
Farnesylation involves the irreversible posttranslational
addition of a 15-carbon lipid tail to the cysteine at the C-termi-
nal end of proteins containing the sequence CAAX (where C is
a cysteine residue, A is any aliphatic amino acid, and X can be
any amino acid), with the resulting cleavage of the final three
residues (19). The membrane association of UCH-L1 in COS7
cells has been reported to be due to farnesylation of an atypical
consensus sequence (CKAA) at its C terminus (9). However, in
contrast to that report and to our own data using cultured neu-
rons, we were unable to detect any appreciable amounts of
UCH-L1M in the membrane fraction of COS7 or HEK293T
cells, although they expressed endogenous UCH-L1C. UCH-
L1Mwas detectedweakly inmouse neuroblastoma-derivedN2a
cells (5.8%) compared with cultured cortical neurons
(32.2%) (Fig. 1, D and E). To test whether the proportion of
UCH-L1M in neurons is linked to neurite outgrowth, we
induced N2a cell differentiation. 24 h of serum starvation pro-
duced neuronal-like processes characteristic of differentiation,
but the proportion of UCH-L1M was unchanged (Fig. 1, F and
H). Taken together, our data strongly suggest that membrane
association occurs selectively in neurons but is not dependent
on differentiation.
Inhibition of Farnesylation Does Not Alter the Localization of
UCH-L1M—Despite UCH-L1 being a predominantly neuronal
protein, the effects of UCH-L1 farnesylation have not been
investigated previously in neurons. We therefore tested the
sensitivity of UCH-L1M to the farnesyltransferase inhibitor
FTI-276. Because membrane-association of H-ras is mediated
by farnesylation at the C terminus (20), as a positive control we
first assessed whether inhibition of farnesyltransferase dis-
rupted localization of H-ras (21). As shown in Fig. 2, A and B,
increasing concentrations of FTI-276 disrupted H-ras mem-
brane binding and led to the appearance of H-ras in the cytoso-
lic fractions. In stark contrast, however, FTI-276 did not alter
the proportions of UCH-L1C and UCH-L1M, indicating that
membrane association of UCH-L1 in neurons is not dependent
on farnesylation.
MembraneAssociation ofUCH-L1 IsNotDependent onMod-
ification at Key Cysteine Residues or Ubiquitin Binding—Sev-
eral posttranslational modifications that generate membrane
association, such as prenylation (farnesylation and geranylgera-
nylation) and palmitoylation, rely on covalent attachments to
cysteine residues. We therefore mutated three cysteine resi-
dues inUCH-L1 (3CS) Cys-90, Cys-152, Cys-220) because these
side chains are likely accessible for modification in the cytosol.
Although Cys-90 is part of the catalytic triad in the active site,
Cys-152 can bind lipid products that mediate the cellular
response to oxidative stress and inflammation (15), and Cys-
220 has been proposed as the site of farnesylation (9). None of
the cysteine residues are predicted to form disulfide bonds, and
mutation to serine was chosen over alanine to better preserve
the space-filling properties of the side chains and to keep any
conformational disruption to a minimum (Fig. 3A).
Mutation of each of the six cysteine residues in HA-tagged
UCH-L1 was tested in N2a cells to assess whether UCH-L1
could still bind covalently to a ubiquitin vinyl methyl ester sui-
cide substrate (Boston Biochem), which forms a bond with
Cys-90 in the active site. Notably, the C152S and C220S
mutants, individually or combined, showed comparable sub-
strate binding compared with the WT, whereas binding was
abolished in the C90Smutant (Fig. 3B). These data suggest that
mutation of any individual cysteine residue does not disrupt
UCH-L1 conformation.
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We next infected cultured cortical neurons with WT or the
triple cysteinemutantHA-UCH-L1 (3CS). As shown in Fig. 3C,
HA-UCH-L1 bound toUbVME, and25% partitioned into the
membrane, consistent with 30% of endogenously expressed
UCH-L1 (Fig. 3, D and E). Therefore, the HA-tagged virally
overexpressed UCH-L1 behaves in a similar manner as endog-
enous protein. Interestingly, 20% of the HA-UCH-L1–3CS
mutant was also present in the membrane fraction, suggesting
FIGURE 1. UCH-L1 exists in both cytosolic and membrane-associated forms in neurons. Cell lines contain much lower levels of membrane-associated
UCH-L1 than neurons.A, UCH-L1 exists in cytosolic andmembrane-enriched fractions ofwhole rat brain. Adultmale rat brainwas homogenized and subjected
to subcellular fractionation. Fractionswere immunoblotted for proteinmarkers to verify enrichment. 30gofproteinwas loaded in each lane.Numbers shown
are in kilodaltons relative to molecular weight standards. P1, nuclear-enriched fraction; P2, crude membranes and synaptosomes; P3, microsomes, including
the endoplasmic reticulum and Golgi; S2, cytosol and microsomes; S3, cytosol; Mito, mitochondria; Syn, synaptosomes. B, UCH-L1 exists in cytosolic and
membrane fractions of cultured cortical neurons. Rat cortical neuronal lysate was subjected to high-speed ultracentrifugation to isolate the soluble cytosolic
supernatant and membrane pellet fractions. Protein distribution was tested by immunoblotting for soluble cytosolic protein (RhoGDI) and transmembrane
protein (GluA1). A proportion of Rac1 in neurons is peripherally associated with the membrane via geranylgeranylation, and the endogenous distribution is
preserved using this protocol. 15 g of protein was loaded in each lane. C, relative proportions of UCH-L1 detected per microgram of protein in the cytosolic
andmembrane fractions of cultured cortical neurons. TheUCH-L1 signalwas quantifiedusing Li-CorOdyssey imaging software.a.u., arbitrary units.D, cell lines
contain much lower levels of UCH-L1M than cultured cortical neurons. Lysates from the indicated clonal cell lines were subjected to high-speed ultracentri-
fugation to isolate the cytosolic and membrane fractions. Protein distribution was tested by immunoblotting for cytosolic protein (RhoGDI), and prenylated
protein (Rac1). The distribution of Rac1 is preserved in cell lines, although the proportions vary between cell lines. UCH-L1 was not detected in themembrane
fraction of COS7 or HEK293T cells and only to aminor extent with increased gain in N2a cells. 20g of protein was loaded in each lane. E, relative proportions
ofUCH-L1detectedpermicrogramof protein in the cytosolic andmembrane fractions of the indicated cell lines. TheUCH-L1 signalwas quantified using Li-Cor
Odyssey imaging software. F, serum starvation induces outgrowth of neuronal-like processes in N2a cells. GFP-transfected N2a cells were exposed to serum
starvation for 24 h and fixed for confocal microscopy. Cell outlines were identified, and images were prepared using ImageJ software with MacBiophotonics
plug-ins. G, differentiation does not alter the proportion of UCH-L1M in N2a cells. Outgrowth of neuronal-like processes was induced in N2a cells with 24-h
serum starvation, and then cells were subjected to ultracentrifugation as before. The proportion of UCH-L1M remained unchanged compared with untreated
N2a cells.H, relative proportions of UCH-L1Mdetectedpermicrogramof protein in themembrane fraction of N2a cells. TheUCH-L1 signalwas quantified using
Li-Cor Odyssey imaging software.
Membrane Association of UCH-L1
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that the cysteinemodification at Cys-90, Cys-152, or Cys-220 is
not involved in membrane partitioning.
Because UCH-L1 has a high affinity for ubiquitin, we tested
whether membrane association of UCH-L1 might arise from
binding to a protein containing a domain resembling a ubiqui-
tin fold. The Asp-30 site on UCH-L1 is required for ubiquitin
binding (22). The D30K mutation abolished UbVME substrate
binding (Fig. 3C), although the overexpressed HA-UCH-L1-
D30K mutant still partitioned into the membrane fraction
(22%) (Fig. 3D). Therefore, together with the data from the
3CS mutant, we conclude that membrane association of
UCH-L1 is not dependent on an interaction with the ubiquitin-
binding region of UCH-L1.
The I93M UCH-L1 point mutation has been linked to a
familial strain of Parkinson disease (23). Interestingly, it has
been reported that the I93Mmutant increases insolubility (24)
and decreases ubiquitin hydrolase activity (23), so we tested if it
altered the proportion of UCH-L1M. Our results indicate that
I93M partitions into themembrane and retains sufficient over-
all structure to bind UbVME to the same extent as WT
UCH-L1.
MembraneAssociation ofUCH-L1 IsNotDependent onMod-
ification to the N- or C-terminal Sequence—To investigate the
possible roles of signaling sequences at the N and C termini in
UCH-L1 membrane association, we removed the first four
N-terminal amino acids (MQLK) and the final two residues
(AA) (Fig. 4A). UCH-L1 has a complex “knotted” backbone
structure, and it has been predicted that even minor N- or
C-terminal truncations would denature the protein (25). Our
data, however, demonstrate that removing the first four resi-
dues or the final two residues from UCH-L1 did not affect its
ability to bind UbVME (Fig. 4B). Furthermore, there was no
significant change to the proportion of HA-UCH-L1 in the
membrane fraction with either the N-terminal truncation
(5–223) or the C-terminal truncation (CTT2, 1–221) (Fig.
4C).
C-terminal Deletion of the Final Four Residues of UCH-L1
(CKAA) Leads to IncreasedMembraneAssociation andDecreased
Solubility—Although theCTT2 truncation behaved the same as
the WT, an HA-tagged C-terminal truncation (CTT4,
1–219), which deleted the final four residues (CKAA) encom-
passing the proposed site of farnesylation, reduced cell viability.
Initially we noticed that UbVME binding was abolished (Fig.
4B), suggesting that the protein conformation had been altered.
Consistent with this, there was a significant loss of the soluble
cytosolic form of UCH-L1, with themajority of the signal being
detected in a 1% Triton X-100-insoluble fraction. There was
also an increase in the proportion of UCH-L1M in neurons
infected with the CTT4 mutant compared with the WT (Fig.
4, C and D).
It has been reported thatUCH-L1 is enriched in the insoluble
protein aggregates, consistent with several types of neurode-
generative disease (3). To investigate whether the CTT4
mutant is aggregating within the neurons, we further analyzed
the Triton X-100-insoluble fraction by resuspending it in a 1%
sarkosyl lysis buffer. Although a small proportion of endoge-
nousUCH-L1 remained in the sarkosyl-insoluble fraction, all of
the HA-UCH-L1 contained in the Triton X-100-insoluble frac-
tion of both WT and CTT4-infected neurons could be solu-
bilized with sarkosyl (Fig. 4E).
C-terminal Deletion of the Final Four Residues of UCH-L1
(CKAA) Disrupts the Protein Secondary Structure—To explore
the possible reasons for the changes in solubility, we analyzed
the secondary structure using circular dichroism. The spectra
show that the truncated protein has a shallower minimum at
222 nm, indicating a slightly reduced -helical content com-
paredwith theWT (Fig. 5A). In each case, the protein is approx-
imately one-third -helical. The most significant difference
between the proteins is the marked increase in aggregation of
truncated UCH-L1, as shown by the greatly increased scatter-
ing evident in the spectrum, especially at lower wavelengths.
C-terminal Deletion of the Final Four Residues of UCH-L1
(CKAA) Leads to Cell Death—Confocal microscopy of hip-
pocampal neurons infected with the different UCH-L1 con-
structs using Sindbis virus revealed significant differences in
the distributions of CTT4 compared with the WT. CTT4
displayed a non-uniform, mostly perinuclear staining and
was largely absent from the processes (Fig. 6A). Further-
more, overexpression of this mutant markedly increased
FIGURE2.The farnesyltransferase inhibitorFTI-276doesnot reduceUCH-
L1M inneurons.A,membrane-associatedH-ras, butnotUCH-L1, is decreased
by farnesyltransferase inhibition. Cultured cortical neuronswere treatedwith
a DMSO control or increasing amounts of the farnesyltransferase inhibitor
FTI-276 (Calbiochem), as indicated, for 48 h and then lysed and subjected to
high-speed ultracentrifugation to separate the cytosolic andmembrane frac-
tions. Immunoblotting for the known farnesylation substrate H-ras shows an
increasing shift from a membrane-associated form to a cytosolic form as the
concentration of FTI-276 increases, whereas the proportion of UCH-L1
remains unaffected. B, relative proportions of UCH-L1M and H-rasM detected
per microgram of protein in the FTI-treated membrane fractions relative to
theDMSO control (n 6 for theDMSO control and 500 nM, and n 5 for both
1 and 3M). Datawere analyzed using one-way analysis of variancewith post
hoc Bonferroni test. *, p 0.05; **, p 0.001. a.u., arbitrary units.
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neuronal cell death, as measured by lactate dehydrogenase
release (Fig. 6B).
DISCUSSION
Given its abundance in neurons, surprisingly little is known
about UCH-L1 and especially the mechanisms and conse-
quences of membrane localization (UCH-L1M). A previous
report proposed that farnesylation mediates membrane associ-
ation in cell lines (9), but the effects in neurons were not deter-
mined. In contrast, in this study, we were unable to detect
UCH-L1M by subcellular fractionation in the HEK293T and
COS7 cells we tested, although these cell lines both expressed
endogenous UCH-L1C. Notably, cell lines such as COS7 and
HEK293T are derived from tissues that, when healthy, do not
express significant levels ofUCH-L1. Furthermore, in non-neu-
ronal cells, UCH-L1 has been implicated in the appearance and
progression of certain cancers (26), and, therefore, the aberrant
expression of UCH-L1 in these cell lines likely arises as a result
of the immortalization process.
Our data from primary cortical cultured neurons indicate
that 30% of UCH-L1 is membrane-associated, and we did
detect low levels of UCH-L1M in N2a cells, which are derived
from a neuroblastoma, suggesting that membrane association
is likely a neuron-specific phenomenon (Fig. 1). The proportion
of UCH-L1M was unchanged in differentiated N2a cells follow-
ing serum starvation, suggesting that, if membrane-association
of UCH-L1 is neuron-specific, it is not dependent on neurite
outgrowth. The identity of the specific membrane(s) with
FIGURE 3. Selected mutations do not reduce membrane-associated UCH-L1M. A, three-dimensional models showing the location of visible mutated or
deleted residues in UCH-L1 using Cn3D software with UCH-L1 PDB codes 2ETL and 3KW5 (bound to UbVME). The Ile-93 residue is buried internally. B, effect of
individual UCH-L1 cysteine mutations on UbVME binding in N2a cells. N2a cells were transfected with HA-UCH-L1 Cys-to-Ser point mutants as indicated. Cell
lysates were incubated with 2 M UbVME to assess the effect of mutation on substrate binding and then immunoblotted (IB) to detect infected HA-UCH-L1
constructs and total (endogenous  infected) UCH-L1. C, 3CS (C90S, C152S, and C220S) and D30K mutations abolish UbVME binding, but I93M does not.
Cultured cortical neurons were infected with Sindbis virus expressing the indicated HA-tagged UCH-L1 constructs. Lysates were incubated with 2M UbVME
to assess the effect ofmutations on substrate binding and then immunoblotted to detect infectedHA-UCH-L1 constructs and total (endogenous and infected)
UCH-L1. D, 3CS (C90S, C152S, and C220S), D30K, and I93Mmutations do not reduce the proportion of UCH-L1M. Cultured cortical neurons were infected with
Sindbis virus expressing the indicated HA-tagged UCH-L1. Lysates were subjected to ultracentrifugation to separate cytosolic and membrane-associated
proteins. The fractions were immunoblotted to detect infected HA-UCH-L1 constructs and total (endogenous and infected) UCH-L1. E, relative proportions of
the indicated HA-UCH-L1M constructs detected per microgram of protein in the membrane fraction relative to the cytosolic fraction (WT, n 9; 3CS, n 3;
D30K, n 5; I93M, n 3). a.u., arbitrary units.
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which UCH-L1 associates has remained unclear because the
very high levels of expression of native UCH-L1 in neurons,
combined with its relatively uniform distribution, make it
difficult to resolve using imaging techniques such as confo-
cal microscopy. Also, unlike the previous report in clonal cell
lines (9), partitioning to the membrane in neurons is not
dependent on farnesylation because neither the farnesyl-
transferase inhibitor FTI-276 nor mutation of the Cys-220
residue to serine (Figs. 2 and 3) reduced the proportion of
UCH-L1M. Furthermore, because farnesylation and gera-
nylgeranylation can only occur at one site at the C terminus,
mutation of Cys-220 precludes involvement of any form of
prenylation.
We therefore explored other possible causes of membrane
association using a range of UCH-L1mutants. Surprisingly, our
results indicate that membrane partitioning of UCH-L1M is
not dependent on its affinity for ubiquitin or ubiquitin-like
domains, an N-terminal signal sequence, or any C-terminal
modification such as glycolipid anchoring. Furthermore, our
mutagenesis also ruled out posttranslational modification of
Cys-152 or Cys-220, or direct lipid binding via these residues as
a route for UCH-L1 membrane association. One possibility is
that UCH-L1M is recruited to and retained at themembrane via
interacting proteins or as part of a membrane-bound complex.
A crystallographic study ofUCH-L1has identified possible pro-
tein-protein interaction sites (27), and although no direct inter-
acting proteins for UCH-L1 have been identified, this appears
to be a promising avenue for future research.
UCH-L1 is enriched in pathogenic insoluble protein deposits
associated with neurodegeneration (28), and an interaction
with -synuclein has been suggested (13). It has been proposed
that UCH-L1 possesses E4 ubiquitin ligase activity, which pro-
motes polyubiquitination of -synuclein to pathologically alter
basal turnover (8). Furthermore, it has been proposed that this
interaction is mediated specifically by farnesylated UCH-L1M
(9), and, on the basis of this finding, small molecule farnesyl-
transferase inhibitor drugs such as LNK-754 are currently in
clinical trials to inhibit or reduce the levels of farnesylated
UCH-L1M (29, 30). Although our study does not preclude
potential roles for FTIs in treating neurodegeneration, our data
FIGURE 4.UCH-L1 C-terminal truncation CTT4 (1–219) leads tomisfolding and decreased solubility. A, three-dimensional model showing the location
of N- and C-terminal truncations using Cn3D software (38) with UCH-L1 PDB code 2ETL. B, deletion of the final four residues of UCH-L1 abolishes UbVME
binding. Cultured cortical neuronswere infectedwith Sindbis virus expressing the indicatedHA-UCH-L1 constructs. Lysateswere incubatedwith 2MUbVME
to assess the effect of mutations on substrate binding. IB, immunoblot. C, deletion of the final four residues of UCH-L1 causes a decrease in protein solubility.
Cultured cortical neurons were infected with Sindbis virus expressing the indicated HA-UCH-L1 constructs. The Triton X-100-insoluble pellet was isolated by
subjecting themembranepellet to a further centrifugation step.HA-CTT4-infectedcells displayeda lossof solubleUCH-L1C andan increase in signal detected
in the Triton X-100-insoluble fraction. D, relative proportions of the indicated HA-UCH-L1 constructs detected per microgram of protein in the membrane
fraction relative to the cytosolic fraction (n 3). Datawere analyzed using one-way analysis of variancewith post hoc Bonferroni test. *, p 0.05. a.u., arbitrary
units. E, TritonX-100-insolubleUCH-L1 canbe solubilizedusing sarkosyl buffer. The1%TritonX-100-insolublepelletwas resuspended in1%sarkosyl buffer and
subjected to further ultracentrifugation to isolate a sarkosyl-soluble fraction. The final sarkosyl-insoluble pellet was resuspended in 2% SDS. 20 l of the
sarkosyl-soluble and -insoluble fractionswere loaded.NoHAsignalwasdetected in the sarkosyl-insoluble fractionsofHA-WTandHA-CTT4-infectedneurons.
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strongly suggest that they do not act by decreasing the mem-
brane association of UCH-L1M.
UCH-L1has an unusual knotted backbone structure, and it is
believed that extensive N- or C-terminal truncations can desta-
bilize the tertiary structure of the protein (25). In addition,
UCH-L1 has been reported to be susceptible to unfolding and
aggregation, either through modification or mutation, leading
to a gain of toxicity (15, 31). For instance, unfoldingmay lead to
increased association with protein aggregates, such as Lewy
bodies (28) and tau tangles observed in Alzheimer disease (14).
These events correlate to decreased levels of soluble UCH-L1C,
but how UCH-L1 participates in these processes is unclear.
Interestingly, expression of a UCH-L1 deletion mutant lacking
the final four residues (CKAA, CTT4) caused a dramatic
increase in neurotoxicity, whereas deletion of the final two res-
idues (AA, CTT2) had no marked effect (Fig. 6). The CTT4
mutant abolished UbVME substrate binding and led to a loss of
soluble cytosolic UCH-L1 with a corresponding increase in a
Triton X-100-insoluble but 1% sarkosyl-soluble aggregated
form. CTT4 showed strong perinuclear staining and a dra-
matic tendency to aggregate, consistent with a loss of tertiary
structure and increased neuronal death.
A common theme that emerges from both point mutation
and oxidative modification studies of the misfolding and/or
aggregation of UCH-L1 is disruption to the central hydropho-
bic core (15, 31). Although it has a knotted primary sequence,
the tertiary structure of UCH-L1 folds into two -helical lobes
surrounding a tightly packed and solvent-inaccessible hydro-
phobic core of -strands (31). Residue Ile-93 is located in -he-
lix3,which directly contacts the6 strand (Fig. 5B). The I93M
mutation is associated with Parkinson disease and has been
reported to decrease UCH-L1 solubility and hydrolytic activity
(24, 31). These effects have been attributed to disruption of the
6 strand in particular as well as 2–4 (31), and it has been
proposed that this leads to increases in UCH-L1 insolubility
(24). However, it should be noted that another study reported
that the I93M mutant is well folded and structurally similar to
thewild-type protein (15). Overall, our data aremost consistent
with the latter finding because we detected little change in the
solubility of the I93M mutant (Fig. 3D).
Cyclopentenone prostaglandins such as 15d-PGJ2 are pro-
duced during an immune response or under oxidative stress.
15d-PGJ2 specifically modifies UCH-L1 at C152 site, leading to
a loss of protein stability (15). Although C152 is situated in a
short unstructured loop covering the active site of the protein,
it was proposed that 15d-PGJ2 acts as a lipophilic wedge to
penetrate into the core of the protein, disrupting the tightly
packed structure of the protein (Fig. 5B). Analogous to this
disruption of the packed core structure by prostaglandins, our
results indicate that disruption of the extreme C terminus may
also have a similar effect and provide a potential mechanism for
how UCH-L1 structure and stability may be regulated by other
forms of oxidative stress.
Crystal structures of UCH-L1 suggest that Lys-221 might be
integral to the tertiary structure by forming intramolecular
bonds to hold the three-dimensional shape of the protein (PDB
code 2ETL, Ref. 27). Removal of the final four residues, 220–
223, fromUCH-L1would remove the intramolecular hydrogen
FIGURE 5.Analysis of the protein structure reveals increased aggregation of CTT4 comparedwith theWT. A, circular dichroic spectroscopy data show
that the CTT4mutant (red line) has a slightly shallowerminimumat 222 nm, indicating that it has amarginally lower-helical content comparedwith theWT
(black line) at 5 M protein concentration in PBS with 1 mM TCEP and 0.01% SDS. In each case, the protein is approximately one-third -helical. There is a
dramatic increase in the tendency of the CTT4mutant to aggregate, as shownby the greatly increased scattering evident in the spectrum, especially at lower
wavelengths.Data arepresentedasmean	S.E. (WTandCTT4,n64).B, topologicalmappingof residues inUCH-L1 associatedwith alteredprotein stability.
-helices are shown in red, and -strands are shown in blue. Residues reported to correlate with changes in protein stability are shown in yellow.
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bonds formed by the Lys-221 residue andwould also expose the
protected 6 strand to the solvent, causing a sufficient distur-
bance to the hydrophobic core that the protein loses significant
tertiary structure without necessarily losing the significant
localized -helical secondary structure. This phenomenon
occurs in themisfolding of other proteins, resulting in the expo-
sure of flexible, previously hidden hydrophobic regions that
mediate aberrant interactions with proteins and cellular mem-
branes. Indeed, these kinds of conformational transitions lead
to the assembly of protein oligomers characteristic of many
neurodegenerative diseases, including amyloid- in Alzheimer
disease and -synuclein in Parkinson disease (32, 33). The
resultant aggregates disrupt essential cellular processes by
forming membrane pores (34), disrupting membrane choles-
terol (35), interfering with protein chaperone machinery (36),
and/or sequestering essential proteins to the aggregates (37).
We therefore propose that exposure of the hydrophobic core
causes a toxic gain of function in which misfolded UCH-L1
aberrantly binds to hydrophobic intracellular membranes, and
this leads to cell death. The CTT4 mutant we report here
represents an extreme form of unfolded UCH-L1. Importantly,
we attribute this to a toxic gain of function rather than a loss of
hydrolytic activity because C90S and D30K do not have the
same effect. Taken together, our findings suggest that modifi-
cations or mutations that alter the folding and/or stability of
UCH-L1 are neurotoxic. The CTT4 truncation provides a
useful new tool for studying how UCH-L1 misfolding and dys-
function lead to protein instability and cell death, which path-
ways are involved, andwhatmeasures can be taken to reduce or
prevent toxicity.
In conclusion, our results demonstrate that membrane asso-
ciation of UCH-L1 is differentially regulated in different cell
types. We investigated a series of possible mechanisms for the
membrane association, and our data indicate that, contrary to a
previous report, farnesylation and/or other cysteine posttrans-
lational modifications are not responsible for membrane parti-
tioning. Therefore, further work is required to define how
UCH-L1 is recruited and retained at membranes selectively in
neurons and to elucidate the functional consequences of this
membrane association.
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